| 2024-04-12 18:15 | CC:NAV | Navco Pharmaceuticals Inc | 0.025 | News Release200 | Navco hires SOF Marketing for $300,000 |
| 2024-03-14 17:35 | CC:NAV | Navco Pharmaceuticals Inc | 0.03 | News Release200 | Navco Pharmaceuticals grants 10-year options |
| 2024-02-28 00:36 | CC:NAV | Navco Pharmaceuticals Inc | 0.04 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2024-02-27 22:58 | CC:NAV | Navco Pharmaceuticals Inc | 0.04 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2024-02-09 22:50 | CC:NAV | Navco Pharmaceuticals Inc | 0.04 | Miscellaneous270 | Navco Pharmaceuticals 14,070,441 warrants repriced |
| 2024-02-07 20:02 | CC:NAV | Navco Pharmaceuticals Inc | 0.035 | Acquisition310 | Navco Pharmaceuticals acquisition |
| 2024-01-30 17:14 | CC:NAV | Navco Pharmaceuticals Inc | 0.035 | News Release200 | Navco lowers warrant exercise price to 10 cents a share |
| 2024-01-18 16:50 | CC:NAV | Navco Pharmaceuticals Inc | 0.04 | News Release200 | Navco Pharma completes acquisition of SL Immuno |
| 2023-12-11 14:48 | CC:NAV | Navco Pharmaceuticals Inc | 0.025 | News Release200 | Navco Pharmaceuticals to acquire SL Immuno Pharma |
| 2023-08-29 22:30 | CC:NAV | Navco Pharmaceuticals Inc | 0.03 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-08-29 22:19 | CC:NAV | Navco Pharmaceuticals Inc | 0.03 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-05-30 19:40 | CC:NAV | Navco Pharmaceuticals Inc | 0.07 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-05-30 19:40 | CC:NAV | Navco Pharmaceuticals Inc | 0.07 | SEDAR MD & A815 | SEDAR MD & A |